Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

The bioenergetic deficits observed in Amyotrophic Lateral Sclerosis result from the disruption of mitochondria-associated ER membranes. Here, the authors show that this disruption impairs the use ...

LAS VEGAS , NV, UNITED STATES, December 16, 2024 /EINPresswire / -- DelveInsight's“Amyotrophic Lateral Sclerosis Insights, Epidemiology, and market Forecast-2034” report offers an in-depth ...

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Medically reviewed by Smita Patel, DO Formerly known as Lou Gehrig’s disease, amyotrophic lateral sclerosis is now commonly referred to as “ALS.” It is a neurological disease that affects motor ...

Epub 2015 Jul 27. Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE. Geographic variation of amyotrophic lateral sclerosis incidence in New Jersey, 2009-2011. Am J Epidemiology 2015;doi: ...

Hawking authored numerous books throughout his career and gave guest lectures around the world despite being paralyzed from amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig’s ...